Barclays has raised its price target for Nutrien (NTR) to $61 from $59, maintaining an Equal Weight rating, driven by higher fertilizer prices and strong demand. Analysts project an average target price of $62.76, indicating an 8.09% upside from the current price of $58.06, while the consensus rating suggests an "Outperform" status. Nutrien's positive outlook is supported by increased retail fertilizer sales and successful acquisitions, alongside a commitment to achieving $200 million in cost savings by 2025.